Remix Therapeutics
MA - Watertown
BiotechnologyFocus: Small molecule therapies designed to reprogram RNA processing
Remix Therapeutics is a life sciences company focused on Small molecule therapies designed to reprogram RNA processing.
Gene Therapy
Funding Stage
PUBLIC
Open Jobs
2
Pipeline & Clinical Trials
REM-422
Myelodysplastic SyndromesClinical Trials (1)
NCT06297941Study of REM-422 in Patients With AML or Higher Risk MDS
Phase 1REM-422
Adenoid Cystic CarcinomaClinical Trials (1)
NCT06118086Study of REM-422 in Patients With Recurrent, Metastatic, or Unresectable Adenoid Cystic Carcinoma
Phase 1/2Open Jobs (2)
Interview Prep Quick Facts
Founded: 2020
Portfolio: 2 clinical trials
Open Roles: 2 active jobs
Hiring Trend
Stable
2
Open Roles
+0
Added
-0
Filled/Removed
Based on last 4 crawl cycles